These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 1705823

  • 41. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V, Dakka T, Plaisancie P, Chayvialle JA, Cuber JC.
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [Abstract] [Full Text] [Related]

  • 42. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T, Cejvan K, Abdel-Halim SM, Efendic S, Schmidt PT, Hellström PM.
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [Abstract] [Full Text] [Related]

  • 43. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
    Jia X, Brown JC, Kwok YN, Pederson RA, McIntosh CH.
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1215-9. PubMed ID: 7882187
    [Abstract] [Full Text] [Related]

  • 44. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G, Thomaseth K, Ahrén B.
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [Abstract] [Full Text] [Related]

  • 45. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB, Buchan AM, Kofod H.
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [Abstract] [Full Text] [Related]

  • 46. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F.
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [Abstract] [Full Text] [Related]

  • 47. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR.
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [Abstract] [Full Text] [Related]

  • 48. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B, Pettersson M, Uvnäs-Moberg K, Gutniak M, Efendic S.
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [Abstract] [Full Text] [Related]

  • 49. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
    Sjöholm A, Sandberg E, Ostenson CG, Efendić S.
    Pancreas; 2000 Apr; 20(3):282-9. PubMed ID: 10766455
    [Abstract] [Full Text] [Related]

  • 50. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
    Schmid R, Schusdziarra V, Aulehner R, Weigert N, Classen M.
    Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
    [Abstract] [Full Text] [Related]

  • 51. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
    Gromada J, Dissing S, Bokvist K, Renström E, Frøkjaer-Jensen J, Wulff BS, Rorsman P.
    Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
    [Abstract] [Full Text] [Related]

  • 52. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    Digestion; 1992 Jul; 52(3-4):214-21. PubMed ID: 1459356
    [Abstract] [Full Text] [Related]

  • 53. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC, Habener JF.
    FEBS Lett; 1991 Feb 25; 279(2):335-40. PubMed ID: 1672112
    [Abstract] [Full Text] [Related]

  • 54. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.
    Diabetes; 1996 Nov 25; 45(11):1524-30. PubMed ID: 8866556
    [Abstract] [Full Text] [Related]

  • 55. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
    Matsuyama T, Komatsu R, Namba M, Watanabe N, Itoh H, Tarui S.
    Diabetes Res Clin Pract; 1988 Oct 14; 5(4):281-4. PubMed ID: 3069410
    [Abstract] [Full Text] [Related]

  • 56. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
    Weir GC, Mojsov S, Hendrick GK, Habener JF.
    Diabetes; 1989 Mar 14; 38(3):338-42. PubMed ID: 2645190
    [Abstract] [Full Text] [Related]

  • 57. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
    Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S.
    Diabetes; 1989 Jul 14; 38(7):902-5. PubMed ID: 2661287
    [Abstract] [Full Text] [Related]

  • 58. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
    Lynn FC, Pamir N, Ng EH, McIntosh CH, Kieffer TJ, Pederson RA.
    Diabetes; 2001 May 14; 50(5):1004-11. PubMed ID: 11334402
    [Abstract] [Full Text] [Related]

  • 59. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells.
    Fehmann HC, Habener JF.
    Endocrinology; 1991 Jun 14; 128(6):2880-8. PubMed ID: 1645253
    [Abstract] [Full Text] [Related]

  • 60. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J, Lins PE, Efendić S.
    Endocrinology; 1982 Apr 14; 110(4):1268-72. PubMed ID: 7037370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.